IV (Intravascular) Catheters Market By Product Type (Peripheral IV Catheters Billion in, Central Venous Catheters (CVCs), Midline Peripheral Catheters, Integrated/Closed IV Catheters), Material (Polyurethane IV Catheter, Silicone IV Catheters, Teflon IV Catheters), End-User (Hospitals Pharmacies, Retail Pharmacies), Region for 2024-2031

IV (Intravascular) Catheter Market Valuation – 2024-2031

The increasing focus on self-care and home-based healthcare is driving the demand for IV catheters that are user-friendly for patients to use outside of clinical settings. As more patients manage their care and self-administer medications at home, there is a growing need for IV catheters designed for ease of use in non-clinical environments. Thus, the growth in self-care and home-based healthcare surged the growth of market size surpassing USD 8.92 Billion in 2024 to reach a valuation of USD 17.49 Billion by 2031.

The rising number of surgical procedures performed in hospitals and ambulatory surgical centers is contributing to the market’s expansion. The need for IV catheters is heightened for perioperative and postoperative treatments, as they play a crucial role in administering fluids, medications, and nutrients during and after surgeries. This increase in surgical activity is driving demand for a wide range of IV catheter products to support patient care throughout the surgical process. Thus, the increasing number of surgical procedures enables the market to grow at a CAGR of 8.78% from 2024 to 2031.

IV (Intravascular) Catheter MarketDefinition/ Overview

An intravenous (IV) catheter is a slender, flexible tube inserted into a vein to facilitate the direct delivery of fluids, medications, or blood products into the bloodstream. This essential medical device is widely utilized across various healthcare settings, including hospitals, clinics, and home care environments, to provide swift and effective treatment for a range of medical conditions.

IV catheters offer a direct and efficient route for administering therapeutic substances, bypassing the digestive system. This method is particularly advantageous for patients who are unable to consume food or fluids orally due to medical conditions, or when there is a need for rapid medication delivery. By ensuring that medications and nutrients are introduced directly into the bloodstream, IV catheters enable precise and immediate therapeutic effects, which is crucial for managing acute conditions and supporting ongoing treatments.

In addition to their use in hospital and clinical environments, IV catheters are increasingly employed in home care settings, where they provide vital support for patients requiring continuous or intermittent treatments. The versatility and efficiency of IV therapy make it a cornerstone of modern medical practice, facilitating comprehensive patient care and enhancing treatment outcomes across diverse healthcare scenarios.

How the Rapid Technological Advancements and Innovations in the Healthcare Sector Surge the Growth of IV Catheters Market?

Rapid technological advancements and innovations in the medical sector surge the growth of IV catheters market. Recent developments include novel peripheral IV catheters, central venous catheters, and midline peripheral catheters, which are designed to efficiently administer fluids and medications directly into the patient’s bloodstream. Many of these catheters are coated with medications that are gradually released, helping to alleviate pain and reduce inflammation.

The market for central IV catheters is particularly dynamic, with ongoing innovations in tip design, material usage, and delivery mechanisms. Vendors are introducing advanced needles that can withstand high pressure and are compatible with power injectable systems. These improvements aim to enhance patient comfort and minimize the risk of bloodstream infections, driving market growth.

The rising demand for multi-lumen central venous catheters (CVCs) is a notable trend. Multi-lumen CVCs offer significant advantages for patients who require frequent intravenous medications, blood transfusions, laboratory tests, and parenteral nutrition. They reduce the need for multiple catheter insertions and lower the risk of infections, making them highly desirable. Vendors are increasingly focused on developing and offering these multi-lumen catheters to enhance efficiency and improve sales volume and profit margins.

Technological advancements also include the use of nanotechnology to enhance catheter materials. Nanoscale modifications improve biocompatibility and reduce thrombogenicity, which decreases the risk of clot formation. Additionally, integrating antimicrobial coatings on catheters helps prevent bacterial growth, reducing the incidence of catheter-related infections. Ultrasound technology is being employed to guide catheter insertion, which improves accuracy, reduces complications, and increases the success rate of procedures. These innovations collectively drive the growth of the global central IV catheter market, as they address key challenges and improve patient outcomes.

The demand for intravenous catheters is expected to rise significantly due to several factors. Increasing regulatory approvals for IV catheters are boosting market confidence and availability. The growing incidence of chronic disorders, including neurological, cardiovascular, and urological conditions, is driving the need for these devices, particularly as the elderly population continues to expand and requires more frequent medical interventions. Additionally, heightened awareness regarding the prevention and control of catheter-related bloodstream infections (CRBSI) is anticipated to further fuel demand. As both healthcare providers and patients become more focused on infection control and improving patient safety, the use of intravenous catheters is likely to increase throughout the forecast period.

How the Infection Risk Associated with the catheter bloodstream Impede the Growth of IV Catheter Market?

The risk of infection, such as catheter-related bloodstream infections (CRBSIs). These infections present significant challenges, prompting healthcare facilities to adopt stringent protocols to mitigate risks. However, these measures can increase operational complexities and overall costs, adding pressure to healthcare systems and manufacturers alike. Patient discomfort is another critical issue. The insertion and maintenance of IV catheters can cause pain and discomfort, which may lead to patient dissatisfaction. This discomfort can sometimes result in patients refusing treatment or discontinuing use, affecting the effectiveness and acceptance of IV therapy.

Product recalls pose a substantial risk as well. Any issues related to catheter quality, such as complications or manufacturing defects, can lead to recalls. Such incidents damage the reputation of manufacturers and undermine market confidence, potentially impacting sales and market dynamics. Cost pressures further complicate the landscape. The rising costs associated with advanced catheter technologies and the need for continual innovation can exert significant pressure on pricing and profitability for manufacturers. Balancing affordability with technological advancements remains a challenge in a cost-sensitive market.

Additionally, regulatory hurdles are a considerable restraint. The stringent regulatory requirements for device approval and market entry can extend development timelines and increase costs. Navigating these regulations requires substantial investment and resources, which can delay the introduction of new products and impact overall market growth.

Category-Wise Acumens

How the Low-Cost Therapy and Highly Favored Clinical Settings Surge the Growth of the Peripheral IV Catheter Segment?

The peripheral IV catheter segment significantly dominates the IV catheter market. Peripheral intravenous catheters (PIVCs) are increasingly favored in clinical settings for their ease of installation and removal, offering a more comfortable and minimally invasive option for obtaining intravenous therapy. This approach enhances patient satisfaction and proves to be more cost-effective compared to midline peripheral catheters and central venous catheters. The low cost of PIVCs, coupled with their user-friendly nature, positions them as a popular choice in various medical procedures.

The market for PIVCs is expected to experience growth driven by strategic initiatives from industry players, such as the introduction of innovative products, strategic partnerships, and mergers and acquisitions. This peripheral catheter significantly reduces the risk of needle stick injuries and blood exposure, contributing to safer intravenous access for healthcare providers.

Furthermore, the increasing preference for minimally invasive procedures is fueling the demand for PIVCs. These procedures are associated with shorter recovery times, reduced discomfort, and lower risk of complications, making them appealing for both patients and healthcare practitioners. PIVCs are commonly used to administer anesthetics and medications during such procedures, underscoring their importance in modern medical practices. As the adoption of minimally invasive techniques continues to rise, the demand for PIVCs is expected to grow, driven by their practical benefits and the ongoing evolution of medical technologies.

How do the Increasing Medical Procedures and Escalating Hospitalization Rates Foster the Growth Hospitals Pharmacies Segment?

The Hospital Pharmacies segment significantly dominates the IV Catheter Market. The global increase in hospitalization rates and the growing volume of medical procedures requiring IV fluid and solution infusion are major drivers of the IV catheter market. Hospitals remain the primary setting for IV catheter use, accounting for the majority of sales and continuing to dominate the market.

In these healthcare facilities, hospital pharmacies and stores play a crucial role in the distribution and storage of pharmaceuticals, including IV catheters. These on-site pharmacies manage a broad range of medications, from standard treatments to specialized and experimental drugs. As hospitals prioritize patient safety, there is a significant focus on minimizing the risks associated with IV catheter use, such as infections and complications.

In addition, to these concerns, hospitals are increasingly demanding IV catheters that feature advanced safety features. For instance, IV catheters with antimicrobial coatings are sought after for their ability to reduce infection risks, while needleless connectors are preferred for their role in minimizing needle-stick injuries and enhancing overall safety. This trend highlights the hospital’s commitment to improving patient outcomes and safety through the adoption of more sophisticated and safer catheter technologies.

Gain Access to IV (Intravascular) Catheter Market Report Methodology

Country/Region-wise Acumens

How do the Increasing Geriatric Population and the Extensive Network of Hospitals in the Region Surge the Growth of the IV (Intravascular) Catheter Market?

North America substantially dominates the IV (Intravascular) catheter market.  The increasing prevalence of chronic disorders and the rising geriatric population contribute to a higher demand for IV catheters, driven further by the presence of leading manufacturers such as Boston Scientific Corporation, BD, and Teleflex Incorporated. These companies are positively impacting regional market growth through their innovations and market activities. The extensive network of hospitals, clinics, and ambulatory care centers worldwide creates a substantial and consistent demand for IV catheters. The broad availability of these healthcare facilities ensures that a large patient base, requiring intravenous treatments for various conditions, has reliable access to essential catheter devices. The increasing global elderly population is particularly susceptible to chronic diseases that often necessitate prolonged or frequent IV therapy. As the number of aging individuals rises, so does the need for IV catheters to manage age-related health issues effectively and provide ongoing medical care.

Favorable government policies, heightened public awareness, and the presence of highly qualified medical professionals and renowned healthcare facilities further bolster the market’s expansion in North America. The high incidence of chronic diseases is anticipated to increase hospital admissions, which in turn will drive demand for vascular catheterization and vein access treatments. Innovations such as advanced biocompatible materials, antimicrobial coatings, and user-friendly designs are improving patient outcomes and driving market growth. These advancements contribute to safer, more effective catheterization processes, benefiting patients and healthcare providers.

Additionally, strategic initiatives by market players, including product innovations and various other activities, are contributing to the region’s market growth. North America is expected to hold the largest share of the intravascular catheters market during the forecast period, largely due to the increasing incidence of renal diseases. The increasing emphasis on reducing healthcare-associated infections (HAIs) and improving patient safety. This focus has led to the development and adoption of advanced IV catheters equipped with features such as needleless connectors and antimicrobial coatings. Stringent regulations and guidelines surrounding infection control are propelling the market for these advanced safety-oriented products.

How the Increasing Investments in the Healthcare Sector and Growing Incidence of Chronic Conditions Foster the Growth of IV (Intravascular) Catheter Market?Bottom of Form

Investments in expanding and upgrading healthcare facilities fueling strong demand for medical devices, including IV catheters. The establishment of new hospitals, clinics, and specialized care centers, along with the enhancement of existing infrastructure, ensures that a wide array of medical devices, including IV catheters, are required to support advanced patient care. The growing incidence of chronic conditions such as diabetes, cancer, and cardiovascular diseases is driving a heightened need for long-term IV therapy. As these diseases become more prevalent, the demand for IV catheters increases, given their essential role in the ongoing management and treatment of these conditions. In countries like Japan and South Korea, the rapidly aging population is leading to a greater need for IV catheters. Older adults are more prone to chronic illnesses and age-related health issues that often require intravenous treatment. This demographic shift is substantially driving the demand for IV catheters to address the specific needs of the elderly.

Increasing disposable incomes are enhancing access to healthcare services and advanced medical treatments. As individuals’ financial capabilities improve, they are more likely to seek high-quality medical care and invest in advanced medical technologies, including IV catheters. This rise in disposable income contributing to the broader adoption of these medical devices. Government support for healthcare infrastructure development and a strong emphasis on patient safety are pivotal in driving market growth. Various government initiatives aim to improve healthcare access, implement rigorous infection control measures, and promote the use of advanced medical devices. These efforts are supporting the expansion of the IV catheter market by fostering a safer and more efficient healthcare environment.

Competitive Landscape

The IV (Intravascular) catheter market is characterized by a mix of established global players and regional manufacturers. The industry is highly competitive, with companies focused on product innovation, cost-efficiency, and strong distribution networks.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the IV (Intravascular) catheter market include

• BD (Becton, Dickinson, and Company)
• Braun Melsungen AG
• ICU Medical, Inc.
• Teleflex Incorporated
• Terumo Corporation
• Smiths Medical
• Medtronic
• Abbott Laboratories
• Edwards Lifesciences Corporation
• Coloplast A/S
• Stryker Corporation
• Cook Medical
• Merit Medical Systems, Inc.
• Vygon
• Nipro Corporation
• Medsource Labs

Latest Developments

• In October 2023, Linear Health Sciences announced that the Orchid SRV safety release valve had achieved US FDA approval. The device was approved for use with all IV access procedures; the catheter was designed to reduce the likelihood of IV catheter failure and repair in hospitals.
• In April 2023, BD announced the Prevue II System, a completely innovative, user-friendly sophisticated ultrasound system with a tailored probe designed to assist surgeons in accurately implanting intravenous placements.
• In September 2022, B. Braun SE announced the acquisition of Starboard Medical, Inc.’s cutting-edge Clik-FIX catheter protection device portfolio. With this acquisition, B. Braun added to its track record of creating new products and programs that improve patient outcomes and experiences with peripheral intravenous (IV) therapy.
• In January 2022, ICU Medical, Inc. Smiths Medical announced the acquisition of Smiths Group plc. Smith’s Medical specializes in syringe and mobile infusion devices, vascular access, and critical care solutions.

Report Scope

IV (Intravascular) Catheter Market, By Category

Product Type

• Peripheral IV Catheters
• Central Venous Catheters (CVCs)
• Midline Peripheral Catheters
• Integrated/Closed IV Catheters

Material

• Polyurethane IV Catheter
• Silicone IV Catheters
• Teflon IV Catheters

End-User

• Hospitals Pharmacies
• Retail Pharmacies

Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region